© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Etilefrine Hydrochloride serves as a synthetic sympathomimetic amine, often used in the pharmaceutical industry for its effects on blood pressure and cardiac output. Its action stems from its ability to stimulate the adrenergic receptors, increasing cardiac contractility and vascular tone. Developed in the search for effective treatments targeting circulatory collapse and hypotension, the compound’s therapeutic utility highlights its essential role among cardiovascular acting agents.
In pure form, Etilefrine Hydrochloride appears as a crystalline solid, typically white or nearly white in color. Its solid-state allows precise weighing and easy integration during manufacturing. The substance’s molecular formula is C10H17NO2·HCl, with a molecular weight close to 219.71 g/mol, indicating moderate complexity for an organic pharmaceutical. Specific density sits around 1.1 g/cm³, offering clues for storage, packaging, and resonance with solution calculations. This compound dissolves easily in water, yielding a clear solution; this property is vital since intravenous or oral formulations rely on rapid and predictable dissolution. Acids, alcohols, and organic solvents generally act as compatible carriers, further expanding its use in a variety of finished products like ampoules and oral drops. As a raw material, the compound handles well within standard temperature and humidity controls—thermal stability makes shipping and safeguarding a manageable process for most laboratories and manufacturers.
The structure of Etilefrine Hydrochloride features a phenolic core, etched with an ethyl side chain and an amino group. These chemical moieties drive its agonistic activity on adrenergic receptors. Knowledge of this configuration is crucial for those developing next-generation cardiovascular agents, especially when exploring slight structural modifications to enhance specificity, reduce unwanted side effects, or optimize absorption and half-life. Stereochemistry matters: enantiomers sometimes present different pharmacological responses. Laboratories pay close attention to chirality when planning synthesis or during quality assurance, because even seemingly minor differences can translate to notable clinical outcomes.
Manufacturers provide Etilefrine Hydrochloride in a range of forms and purities tailored to specific application needs. Standard presentation involves crystalline powder, but other physical states like flakes, pearls, or fine granules exist for improved flexibility during formulation. Bulk lots arrive in robust, sealable containers to avoid moisture pickup or accidental contamination. The Harmonized System (HS) Code used globally for trade classification typically falls under pharmaceuticals and organic chemicals, providing customs officers and regulatory agencies a direct reference for import, export, and tariff enforcement. In many countries, the number 2922.49 captures its essence under “Amines and their derivatives” classification. Handling protocols enforce tight control over labelling and documentation, both to comply with international law and to guarantee traceability at all points along the supply chain.
Safety holds top priority in environments where bulk Etilefrine Hydrochloride is handled or stored. Classified as moderately hazardous at high doses, it can cause irritation to mucous membranes, eyes, and skin. Accidental inhalation or ingestion brings acute risks, including rapid heart rate or spikes in blood pressure, so workplace standards require gloves, goggles, and dust-mitigating storage methods. Controlled physical contact and enclosed transfer systems help limit exposure. Chemical safety protocols, dictated by Material Safety Data Sheets (MSDS) and local legislation, spell out environmental controls and emergency actions if accidental release or exposure threatens workplace health. Safe disposal means strictly following all hazardous chemical guidelines—this prevents contamination of water sources, municipal waste, and air. As someone who has spent years in research environments, nothing replaces clear labeling, well-maintained stock solutions, and frequent staff refreshers on spill responses.
Etilefrine Hydrochloride’s use as a raw material underscores its practical value. Pharmaceutical companies deploy it as an essential API (active pharmaceutical ingredient) for making oral and injectable formulations. The compound mixes effortlessly into solvents at room temperature, resulting in stable, transparent solutions—a necessity for clinical injections and reliable dosing accuracy. Formulators count on its known density, solubility parameters, and reactivity profile. Beyond medicine, a solid regulatory framework surrounding the importing and exporting of Etilefrine Hydrochloride assures only qualified handlers gain access, further reducing misapplication risks or diversion into nonmedical contexts. Ongoing research may reveal new indications or synthesis pathways, and monitoring both demand and safety outcomes will help shape best practices for years to come.
The most pressing issues with Etilefrine Hydrochloride arise from improper storage conditions, inconsistent purity, and accidental exposure. Real improvement comes with investment in dedicated storage facilities—controlled humidity and temperature directly preserve chemical stability and effectiveness. Frequent batch verification through advanced chromatography and spectroscopy gives assurance that actual purity matches label claims. Investments in staff training prevent workplace accidents and ensure new employees know how to handle spills and respond to exposure events without hesitation. Collaboration between manufacturers, shippers, and end-users builds a safety culture that lowers the chance for costly recalls, regulatory penalties, or dangerous health incidents. On the regulatory front, supporting consistent, science-based global standards for hazardous labelling and documentation makes movement across borders less risky—and boosts consumer confidence that every batch meets strict specifications.
